Transcriptional analysis of doxorubicin‐induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines
- 3 September 2009
- journal article
- Published by Wiley in Liver International
- Vol. 29 (9) , 1338-1347
Abstract
Hepatoma is either intrinsically resistant to chemotherapy or response to it but later develop resistance. The aim of this study was to clarify the relationship of treatment with doxorubicin (Dox) in hepatoma HepG2 cells and drug resistance developed by Dox. We have analysed the bioactivities and gene expression profiles of multidrug resistant (MDR) HepG2/DR cell line and its parental HepG2 cell, which were exposure to Dox. We confirmed that Dox-induced apoptosis of HepG2 cells in a time-dependent manner; cDNA microarray and hierarchical cluster analysis demonstrate that the features of the transcriptional programme of the later response to Dox in HepG2 cells and MDR HepG2/DR cells have a common character, which is upregulation of stress response, cytoskeleton, ubiquitin-proteasome pathway and repressed G-protein signal transduction system; differentially expressed genes in MDR HepG2/DR such as drug transporters and tumour-associated antigens were verified at the levels of mRNA by semiquantitative reverse transcriptase-polymerase chain reaction. These results reveal novel co-ordinated changes that occurred in resistant HepG2 cells to survive from cell apoptosis elicited by Dox treatment.Keywords
This publication has 35 references indexed in Scilit:
- Wilms' Tumor 1 Gene Expression in Hepatocellular Carcinoma Promotes Cell Dedifferentiation and Resistance to ChemotherapyCancer Research, 2009
- TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistanceInternational Journal of Cancer, 2008
- Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by DexrazoxaneCancer Research, 2007
- Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cellsLaboratory Investigation, 2005
- Discriminating two classes of toxicants through expression analysis of HepG2 cells with DNA arraysToxicology in Vitro, 2003
- Role of Rel/NF‐κB transcription factors in apoptosis of human hepatocellular carcinoma cellsCancer, 2002
- Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell linesCancer Chemotherapy and Pharmacology, 2002
- Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNALife Sciences, 2000
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Topoisomerase-targeting antitumor drugsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1989